Maria Paula Oliveira Gomes

Dr. Maria Paula Oliveira Gomes

Universidade de São Paulo, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2021 in Gene Therapy
Verified
Journal Article
Closed access
PDF file
Gileade Pereira FreitasGileade Pereira Freitas
Gileade Pereira Freitas
HLHelena B. Lopes
Helena B. Lopes
ASAlann T. P. Souza
Alann T. P. Souza
MGMaria Paula Oliveira Gomes
Maria Paula Oliveira Gomes
GQGeorgia K. Quiles
Georgia K. Quiles
Adalberto Luiz RosaAdalberto Luiz Rosa
Adalberto Luiz Rosa

28 January 2024 in Life Sciences
Verified
Journal Article
Closed access
ASAlann Thaffarell Portilho Souza
Alann Thaffarell Portilho Souza
GFGileade Pereira Freitas
Gileade Pereira Freitas
HLHelena Bacha Lopes
Helena Bacha Lopes
DWDenise Weffort
Denise Weffort
LALeticia Faustino Adolpho
Leticia Faustino Adolpho
Adalberto Luiz RosaAdalberto Luiz Rosa
Adalberto Luiz Rosa

Verified
Journal Article
Open access
PDF file
LALetícia Faustino Adolpho
Letícia Faustino Adolpho
Larissa RibeiroLarissa Ribeiro
Larissa Ribeiro
Gileade Pereira FreitasGileade Pereira Freitas
Gileade Pereira Freitas
HLHelena Bacha Lopes
Helena Bacha Lopes
MGMaria Paula Oliveira Gomes
Maria Paula Oliveira Gomes
Adalberto Luiz RosaAdalberto Luiz Rosa
Adalberto Luiz Rosa
Background: Tissue engineering and cell therapy have been the focus of investigations on how to treat challenging bone defects. This study aimed to produce and characterize a P(VDF-TrFE)/BaTiO3 scaffold and evaluate the effect of mesenchymal stem cells (MSCs) combined with this scaffold and photobiomodulation (PBM) on bone repair. Methods and results: P(VDF-TrFE)/BaTiO3 was synthesized using an electrospinning technique and presented physical and chemical properties suitable for bone tissue engineering. This scaffold was implanted in rat calvarial defects (unilateral, 5 mm in diameter) and, 2 weeks post-implantation, MSCs were locally injected into these defects (n = 12/group). Photobiomodulation was then applied immediately, and again 48 and 96 h post-injection. The μCT and histological analyses showed an increment in bone formation, which exhibited a positive correlation with the treatments combined with the scaffold, with MSCs and PBM inducing more bone repair, followed by the scaffold combined with PBM, the scaffold combined with MSCs, and finally the scaffold alone (ANOVA, p ≤ 0.05). Conclusions: The P(VDF-TrFE)/BaTiO3 scaffold acted synergistically with MSCs and PBM to induce bone repair in rat calvarial defects. These findings emphasize the need to combine a range of techniques to regenerate large bone defects and provide avenues for further investigations on innovative tissue engineering approaches.

16 September 2022 in Biomimetics
Verified
Journal Article
Open access
PDF file
LZLeonardo Raphael Zuardi
Leonardo Raphael Zuardi
FOFabíola Singaretti de Oliveira
Fabíola Singaretti de Oliveira
RFRoger Rodrigo Fernandes
Roger Rodrigo Fernandes
MGMaria Paula Oliveira Gomes
Maria Paula Oliveira Gomes
Silvia SprianoSilvia Spriano
Silvia Spriano
Paulo Tambasco de OliveiraPaulo Tambasco de Oliveira
Paulo Tambasco de Oliveira
This study evaluates the effects of the availability of exogenous BMP-7 on osteoblastic cells’ differentiation on a nanotextured Ti surface obtained by chemical etching (Nano-Ti). The MC3T3-E1 and UMR-106 osteoblastic cell lines were cultured for 5 and 7 days, respectively, on a Nano-Ti surface and on a control surface (Control-Ti) in an osteogenic medium supplemented with either 40 or 200 ng/mL recombinant mouse (rm) BMP-7. The results showed that MC3T3-E1 cells exhibited distinct responsiveness when exposed to each of the two rmBMP-7 concentrations, irrespective of the surface. Even with 40 ng/mL rmBMP-7, important osteogenic effects were noticed for Control-Ti in terms of cell proliferation potential; Runx2, Osx, Alp, Bsp, Opn, and Smad1 mRNA expression; and in situ ALP activity. For Nano-Ti, the effects were limited to higher Alp, Bsp, and Opn mRNA expression and in situ ALP activity. On both surfaces, the osteogenic potential of UMR-106 cultures remained unaltered with 40 ng/mL rmBMP-7, but it was significantly reduced when the cultures were exposed to the 200 ng/mL concentration. The availability of rmBMP-7 to pre-osteoblastic cells at the concentrations used alters the expression profile of osteoblast markers, indicative of the acquisition of a more advanced stage of osteoblastic differentiation. This occurs less pronouncedly on the nanotextured Ti and without reflecting in higher mineralized matrix production by differentiated osteoblasts on both surfaces.

19 May 2024 in Oral Diseases
Verified
Journal Article
Closed access
ASAlann Thaffarell Portilho Souza
Alann Thaffarell Portilho Souza
GFGileade Pereira Freitas
Gileade Pereira Freitas
HLHelena Bacha Lopes
Helena Bacha Lopes
DWDenise Weffort
Denise Weffort
LALetícia Faustino Adolpho
Letícia Faustino Adolpho
Adalberto Luiz RosaAdalberto Luiz Rosa
Adalberto Luiz Rosa

16 July 2024 in Biology
Verified
Journal Article
Open access
PDF file
LALetícia Faustino Adolpho
Letícia Faustino Adolpho
MGMaria Paula Oliveira Gomes
Maria Paula Oliveira Gomes
Gileade Pereira FreitasGileade Pereira Freitas
Gileade Pereira Freitas
RTRayana Bighetti Trevisan
Rayana Bighetti Trevisan
JRJaqueline Isadora Reis Ramos
Jaqueline Isadora Reis Ramos
Marcio Mateus BelotiMarcio Mateus Beloti
Marcio Mateus Beloti
Therapies to prevent osteoporosis are relevant since it is one of the most common non-communicable human diseases in the world and the most prevalent bone disorder in adults. Since jaboticaba peel extract (JPE) added to the culture medium enhanced the osteogenic potential of mesenchymal stem cells (MSCs) derived from osteoporotic rats, we hypothesized that JPE prevents the development of ovariectomy-induced osteoporosis. Ovariectomized rats were treated with either JPE (30 mg/kg of body weight) or its vehicle for 90 days, starting 7 days after the ovariectomy. Then, the femurs were subjected to microcomputed tomography and histological analyses, and the osteoblast and adipocyte differentiation of MSCs was evaluated. JPE attenuated ovariectomy-induced bone loss, as evidenced by higher bone volume/total volume and trabecular number, along with lower trabecular separation and bone marrow adiposity. These protective effects of JPE on bone tissue are due to its ability to prevent the imbalance between osteoblast and adipocyte differentiation of MSCs, since, compared with MSCs derived from ovariectomized rats treated with vehicle, MSCs treated with JPE exhibited higher gene and protein expression of osteogenic markers and extracellular matrix mineralization, as well as lower gene expression of adipogenic markers. These data highlight the potential therapeutic use of JPE to prevent osteoporosis.